DRD4 (dopamine receptor D4) is a G-protein-coupled receptor mediating dopaminergic neurotransmission in the mesolimbic system, which regulates emotion and complex behavior. The receptor is activated by dopamine, epinephrine, and norepinephrine, triggering inhibitory signaling via Gi/Go proteins that reduce adenylyl cyclase activity 123. DRD4 polymorphisms, particularly the VNTR and 120-bp duplication variants, significantly influence behavioral and psychiatric outcomes. The DRD4 7-repeat allele associates with longevity through increased physical activity 4, while the 2-repeat allele links to substance use disorders through adolescent chr11 pain and delinquency 5. DRD4 gene-gene interactions with COMT and DRD2 modulate antipsychotic response in schizophrenia; the DRD4 120-bp allele combined with COMT Met carriers predicts better clozapine efficacy 67. Early DRD4 polymorphisms associate with eating disturbances 8 and dual diagnosis presentations involving substance use and depression 9. Additionally, DRD4 long alleles interact with frontal brain asymmetry to predict infant temperament development 10. These findings demonstrate DRD4's role as a genetic moderator of environment-behavior interactions across developmental stages and psychiatric conditions.